| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias
|
Lin, Tara L.
|
|
2019
|
84 |
1 |
p. 163-173
|
artikel
|
| 2 |
A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [14C]-labeled idasanutlin and an intravenous tracer dose of [13C]-labeled idasanutlin in a single cohort of patients with solid tumors
|
Pápai, Zsuzsanna
|
|
2019
|
84 |
1 |
p. 93-103
|
artikel
|
| 3 |
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
|
El-Agamy, Sara Emad
|
|
2019
|
84 |
1 |
p. 1-14
|
artikel
|
| 4 |
Clinical characteristics, treatment patterns and outcomes of patients older than 80 years diagnosed with DLBCL in China over a 10-year period
|
Shi, Zhan
|
|
2019
|
84 |
1 |
p. 127-137
|
artikel
|
| 5 |
Clinical implications of an analysis of pharmacokinetics of crizotinib coadministered with dexamethasone in patients with non-small cell lung cancer
|
Lin, Swan
|
|
2019
|
84 |
1 |
p. 203-211
|
artikel
|
| 6 |
Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand–foot syndrome: a newly recognized toxicity
|
Pease, Daniel F.
|
|
2019
|
84 |
1 |
p. 217-221
|
artikel
|
| 7 |
Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?
|
Milano, G.
|
|
2019
|
84 |
1 |
p. 223-224
|
artikel
|
| 8 |
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study
|
Kong, Xiang-Yun
|
|
2019
|
84 |
1 |
p. 155-161
|
artikel
|
| 9 |
Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer
|
Arasaratnam, Malmaruha
|
|
2019
|
84 |
1 |
p. 139-146
|
artikel
|
| 10 |
Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer
|
Li, Bo
|
|
2019
|
84 |
1 |
p. 187-194
|
artikel
|
| 11 |
Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer
|
Li, Zhuanglin
|
|
2019
|
84 |
1 |
p. 61-72
|
artikel
|
| 12 |
Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting
|
Tanaka, Kazuki
|
|
2019
|
84 |
1 |
p. 147-153
|
artikel
|
| 13 |
Orally administered salecan ameliorates methotrexate-induced intestinal mucositis in mice
|
Gao, Yan
|
|
2019
|
84 |
1 |
p. 105-116
|
artikel
|
| 14 |
Pharmacokinetics and safety of lobaplatin plus etoposide in Chinese men older than 65 years with extensive-stage small cell lung cancer: a phase II clinical trial
|
Chen, Jianhua
|
|
2019
|
84 |
1 |
p. 73-81
|
artikel
|
| 15 |
Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancer
|
Lu, Dan
|
|
2019
|
84 |
1 |
p. 175-185
|
artikel
|
| 16 |
Platinum-free interval affects efficacy of following treatment for platinum-refractory or -resistant ovarian cancer
|
Kobayashi-Kato, Mayumi
|
|
2019
|
84 |
1 |
p. 33-39
|
artikel
|
| 17 |
Population pharmacokinetics of PF-05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin®) in patients with HER2-positive metastatic breast cancer
|
Chen, Xiaoying
|
|
2019
|
84 |
1 |
p. 83-92
|
artikel
|
| 18 |
Qualitative and quantitative variations in liver function thresholds among clinical trials in cancer: a need for harmonization
|
Wang, Edwin
|
|
2019
|
84 |
1 |
p. 213-216
|
artikel
|
| 19 |
Renin–angiotensin system inhibitors for countering proteinuria induced by angiogenesis inhibitors: a retrospective observational analysis
|
Hirai, Toshinori
|
|
2019
|
84 |
1 |
p. 195-202
|
artikel
|
| 20 |
Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics
|
Mistry, Hitesh B.
|
|
2019
|
84 |
1 |
p. 51-60
|
artikel
|
| 21 |
Stress resilience and survival among cancer patients: is there any absolute truth?
|
Mormile, Raffaella
|
|
2019
|
84 |
1 |
p. 225-226
|
artikel
|
| 22 |
Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial
|
Verschuur, Arnauld C.
|
|
2019
|
84 |
1 |
p. 41-50
|
artikel
|
| 23 |
Treatment with selenium-enriched Saccharomyces cerevisiae UFMG A-905 partially ameliorates mucositis induced by 5-fluorouracil in mice
|
Porto, Bárbara A. A.
|
|
2019
|
84 |
1 |
p. 117-126
|
artikel
|
| 24 |
Uveal melanoma: physiopathology and new in situ-specific therapies
|
Souto, E. B.
|
|
2019
|
84 |
1 |
p. 15-32
|
artikel
|
Tijdschrift beschrijving